Contribute Try STAT+ Today

Hello, everyone, and welcome to the middle of the week. You made it this far, so why not continue, yes? Meanwhile, another busy day is unfolding here on the Pharmalot campus, where we are mulling over our calendar and plotting our next moves. No doubt, you can relate. After all, this is only the middle of the week and there is so much to be done. So time to get cracking. On that note, here are a few items of interest for you to peruse as your journey begins. Hope you have a productive day and, as always, do keep in touch. …

The two Food and Drug Administration officials in charge of leading reviews of Covid-19 vaccine applications will leave the agency this fall, STAT tells us. Marion Gruber and Phil Krause, collectively have more than 42 years of experience at the FDA and their high-profile departures sparked questions about whether it would affect FDA work during the pandemic. One reason they are leaving is disagreement with the Biden administration over the use of Covid-19 booster shots, according to The New York Times.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!


What is it?

STAT+ is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • STAT+ Conversations
  • Weekly opportunities to engage with our reporters and leading industry experts in live video conversations
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.

Create a display name to comment

This name will appear with your comment